These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
9. [Calcium antagonists and their impact on risk of coronary disease]. Roca-Cusachs A; Rodicio JL Med Clin (Barc); 1996 Oct; 107(14):533-4. PubMed ID: 8999212 [No Abstract] [Full Text] [Related]
10. Are new antihypertensive agents better than old antihypertensive agents in preventing cardiovascular complications? Dickerson LM; Carek PJ J Fam Pract; 2002 Jan; 51(1):9. PubMed ID: 11927051 [No Abstract] [Full Text] [Related]
11. Living up to 100 years of Bayer Healthcare cardiovascular protection - Bayer Healthcare Cardiovascular : 20 years of participation in the South African cardiovascular community. Cardiovasc J Afr; 2009; 20(1):91-4. PubMed ID: 19287826 [No Abstract] [Full Text] [Related]
12. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword. Zanchetti A Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077 [No Abstract] [Full Text] [Related]
15. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy. Leader S; Mallick R; Roht L J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198 [TBL] [Abstract][Full Text] [Related]
16. Calcium-channel blockade and hypertension. Salpeter S N Engl J Med; 1999 Jul; 341(5):372-3. PubMed ID: 10428665 [No Abstract] [Full Text] [Related]
17. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes. Alderman M; Madhavan S; Cohen H Lancet; 1998 Jan; 351(9097):216-7. PubMed ID: 9449897 [No Abstract] [Full Text] [Related]
18. Atorvastatin + amlodipine: new drug. Just a commercial ploy. Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926 [TBL] [Abstract][Full Text] [Related]
19. [Resp-informations]. Bouvier-Colle MH; Cot M; Le Goaster C Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430 [No Abstract] [Full Text] [Related]
20. [Large scale clinical trials of calcium channel blockers on the prevention of cardiovascular diseases]. Shimamoto K Clin Calcium; 2005 Oct; 15(10):1609-14. PubMed ID: 16199905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]